BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10842196)

  • 1. Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes.
    Riker AI; Kammula US; Panelli MC; Wang E; Ohnmacht GA; Steinberg SM; Rosenberg SA; Marincola FM
    Int J Cancer; 2000 Jun; 86(6):818-26. PubMed ID: 10842196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients.
    Spagnoli GC; Schaefer C; Willimann TE; Kocher T; Amoroso A; Juretic A; Zuber M; Luscher U; Harder F; Heberer M
    Int J Cancer; 1995 Oct; 64(5):309-15. PubMed ID: 7591302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune selection after antigen-specific immunotherapy of melanoma.
    Riker A; Cormier J; Panelli M; Kammula U; Wang E; Abati A; Fetsch P; Lee KH; Steinberg S; Rosenberg S; Marincola F
    Surgery; 1999 Aug; 126(2):112-20. PubMed ID: 10455872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunogenic properties of melanoma-associated antigens recognized by cytotoxic T lymphocytes.
    Kirkin AF; Dzhandzhugazyan K; Zeuthen J
    Exp Clin Immunogenet; 1998; 15(1):19-32. PubMed ID: 9619397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage.
    Lupetti R; Pisarra P; Verrecchia A; Farina C; Nicolini G; Anichini A; Bordignon C; Sensi M; Parmiani G; Traversari C
    J Exp Med; 1998 Sep; 188(6):1005-16. PubMed ID: 9743519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients.
    Akiyama Y; Maruyama K; Tai S; Takikawa M; Ohshita C; Yamamoto A; Yamazaki N; Kiyohara Y; Yamaguchi K
    Int J Oncol; 2008 Sep; 33(3):433-41. PubMed ID: 18695871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigens.
    Castelli C; Tarsini P; Mazzocchi A; Rini F; Rivoltini L; Ravagnani F; Gallino F; Belli F; Parmiani G
    J Immunol; 1999 Feb; 162(3):1739-48. PubMed ID: 9973437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Pmel17/gp100 expression in primary human tissue specimens: implications for melanoma immuno- and gene-therapy.
    Wagner SN; Wagner C; Schultewolter T; Goos M
    Cancer Immunol Immunother; 1997 Jun; 44(4):239-47. PubMed ID: 9222283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma-associated antigens recognized by cytotoxic T lymphocytes.
    Kirkin AF; Dzhandzhugazyan K; Zeuthen J
    APMIS; 1998 Jul; 106(7):665-79. PubMed ID: 9740504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAGE-1 expression threshold for the lysis of melanoma cell lines by a specific cytotoxic T lymphocyte.
    Lethé B; van der Bruggen P; Brasseur F; Boon T
    Melanoma Res; 1997 Aug; 7 Suppl 2():S83-8. PubMed ID: 9578421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription of the gene encoding melanoma-associated antigen gp100 in tissues and cell lines other than those of the melanocytic lineage.
    Brouwenstijn N; Slager EH; Bakker AB; Schreurs MW; Van der Spek CW; Adema GJ; Schrier PI; Figdor CG
    Br J Cancer; 1997; 76(12):1562-6. PubMed ID: 9413942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-testis and melanocyte-differentiation antigen expression in malignant glioma and meningioma.
    Syed ON; Mandigo CE; Killory BD; Canoll P; Bruce JN
    J Clin Neurosci; 2012 Jul; 19(7):1016-21. PubMed ID: 22534618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells.
    Liu G; Ying H; Zeng G; Wheeler CJ; Black KL; Yu JS
    Cancer Res; 2004 Jul; 64(14):4980-6. PubMed ID: 15256472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells.
    Le Poole IC; Riker AI; Quevedo ME; Stennett LS; Wang E; Marincola FM; Kast WM; Robinson JK; Nickoloff BJ
    Am J Pathol; 2002 Feb; 160(2):521-8. PubMed ID: 11839572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of melanoma-associated antigens in short-term melanoma cultures detected by RT-PCR and subsequent ELISA.
    Hofbauer GF; Dummer R; Laine E; Burg G
    Arch Dermatol Res; 1998 Aug; 290(8):458-61. PubMed ID: 9763311
    [No Abstract]   [Full Text] [Related]  

  • 16. Culture of melanoma cells in 3-dimensional architectures results in impaired immunorecognition by cytotoxic T lymphocytes specific for Melan-A/MART-1 tumor-associated antigen.
    Ghosh S; Rosenthal R; Zajac P; Weber WP; Oertli D; Heberer M; Martin I; Spagnoli GC; Reschner A
    Ann Surg; 2005 Dec; 242(6):851-7, discussion 858. PubMed ID: 16327495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of MAGE, gp100 and tyrosinase genes in uveal melanoma cell lines.
    Luyten GP; van der Spek CW; Brand I; Sintnicolaas K; de Waard-Siebinga I; Jager MJ; de Jong PT; Schrier PI; Luider TM
    Melanoma Res; 1998 Feb; 8(1):11-6. PubMed ID: 9508371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laser scanning cytometry evaluation of MART-1, gp100, and HLA-A2 expression in melanoma metastases.
    Mocellin S; Fetsch P; Abati A; Phan GQ; Wang E; Provenzano M; Stroncek D; Rosenberg SA; Marincola FM
    J Immunother; 2001; 24(6):447-58. PubMed ID: 11759068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
    Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC
    Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression.
    Kawakami Y; Eliyahu S; Jennings C; Sakaguchi K; Kang X; Southwood S; Robbins PF; Sette A; Appella E; Rosenberg SA
    J Immunol; 1995 Apr; 154(8):3961-8. PubMed ID: 7706734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.